From DCAT Value Chain Insights (VCI)
The Pharmaceutical Research and Manufacturers of America (PhRMA) has named Joaquin Duato as the new chairman of PhRMA’s board of directors. Mr. Duato is currently worldwide chairman, pharmaceuticals at Johnson & Johnson (J&J). Mr. Duato formerly held the position of chairman-elect of the PhRMA board and succeeds George Scangos, who has stepped down as chief executive officer of Biogen.
Mr. Duato has served as worldwide chairman, pharmaceuticals at J&J since January 2011. During his 28-year career at J&J, Mr. Duato has worked across the company’s pharmaceuticals and medical device business segments, held regional chairman roles, and led local market businesses in a variety of countries and regions.
Source: The Pharmaceutical Research and Manufacturers of America
Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT).
Learn more and sign up to receive a complimentary subscription